drugset

drugset / Trial / NCT01177644

Safety and Preliminary Efficacy Study of PDS-1.0 in Patients With Neovascular AMD

NCT01177644 ↗

Phase 1 Withdrawn Forsight Vision4

NaSingle-groupOpen-labelTreatment

Summary

This study will evaluate the safety and preliminary effectiveness of PDS 1.0 in patients with neovascular AMD.

Timeline

Start: 2011-01
Primary completion: 2011-07
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	PDS 1.0	Unknown	—	—

Indications